Skip to main content
Top
Published in: International Urology and Nephrology 4/2015

01-04-2015 | Nephrology - Original Paper

Nationwide renal biopsy data in Lithuania 1994–2012

Authors: Ernesta Brazdziute, Marius Miglinas, Elita Gruodyte, Janina Priluckiene, Algirdas Tamosaitis, Inga Arune Bumblyte, Vytautas Kuzminskis, Soneta Burbaickaja, Marija Sakalauskienė, Augustina Jankauskienė, Rimante Cerkauskiene, Birute Pundziene, Arvydas Laurinavicius

Published in: International Urology and Nephrology | Issue 4/2015

Login to get access

Abstract

Background

Our aim was to evaluate the incidence of biopsy-proven kidney diseases in Lithuania and to compare their changes in three different time intervals. All Lithuanian kidney biopsies were performed in the National Center of Pathology, enabling analysis at the national level.

Methods

The native kidney biopsy data were reviewed, and incidence of renal disorders and patient demographics were compared during three time intervals: 1994–1999, 2000–2006, and 2007–2012.

Results

A total of 5,368 kidney biopsies were performed, including 3,640 native kidney and 1,728 kidney transplant biopsies; 59.5 % (2,165) of the native kidney biopsies were classified as primary glomerulopathies. The most common entity was IgA nephropathy (737; 34.0 %), followed by focal segmental glomerulosclerosis (285; 13.2 %) and membranoproliferative glomerulonephritis (256; 11.8 %). Prominent decrease in incidence of membranoproliferative glomerulonephritis (16.8 to 8.7 % from the first to third time interval) and increase in (mainly, pauci-immune) crescentic glomerulonephritis (6.2 to 15.3 %) were noted over the study period. In a subgroup of 427 pediatric native kidney biopsies, IgAN accounted for 24.9 % of biopsies. The incidence of MCNS increased dramatically from the first to third time interval (6.3 to 25.4 %), while the number of MPGN increased in the second time interval (from 7.2 to 8.9 %) but decreased in the third one (to 4.4 %).

Conclusions

Decrease in relative incidence of membranoproliferative glomerulonephritis, most likely, reflects improvement in socioeconomic conditions, while relative increase in crescentic glomerulonephritis is interpreted as improved diagnostics of the disease.
Literature
1.
go back to reference Rychlik I, Jancova E, Tesar V, Kolsky A, Lacha J, Stejskal J, Stejskalova A, Dusek J, Herout V (2004) The Czech registry of renal biopsies. Occurrence of renal diseases in the years 1994–2000. Nephrol Dial Transpl 19:3040–3049CrossRef Rychlik I, Jancova E, Tesar V, Kolsky A, Lacha J, Stejskal J, Stejskalova A, Dusek J, Herout V (2004) The Czech registry of renal biopsies. Occurrence of renal diseases in the years 1994–2000. Nephrol Dial Transpl 19:3040–3049CrossRef
2.
go back to reference Heaf J, Løkkegaard H, Larsen S (2004) The epidemiology and prognosis of glomerulonephritis in Denmark 1985–1997. Nephrol Dial Transpl 14:1889–1897CrossRef Heaf J, Løkkegaard H, Larsen S (2004) The epidemiology and prognosis of glomerulonephritis in Denmark 1985–1997. Nephrol Dial Transpl 14:1889–1897CrossRef
3.
go back to reference Gesualdo L, Di Palma AM, Morrone LF, Strippoli GF, Schena FP (2004) Italian Immunopathology Group, Italian Society of Nephrology. The Italian experience of the national registry of renal biopsies. Kidney Int 66:890–894CrossRefPubMed Gesualdo L, Di Palma AM, Morrone LF, Strippoli GF, Schena FP (2004) Italian Immunopathology Group, Italian Society of Nephrology. The Italian experience of the national registry of renal biopsies. Kidney Int 66:890–894CrossRefPubMed
4.
go back to reference Horvatic I, Tisljar M, Bulimbasic S, Bozic B, GalesicLiubanovic D, Galesic K (2013) Epidemiologic data of adult native biopsy-proven renal diseases in Croatia. Int Urol Nephrol 45:1577–1587CrossRefPubMed Horvatic I, Tisljar M, Bulimbasic S, Bozic B, GalesicLiubanovic D, Galesic K (2013) Epidemiologic data of adult native biopsy-proven renal diseases in Croatia. Int Urol Nephrol 45:1577–1587CrossRefPubMed
5.
go back to reference Rivera F, Lopez-Gomez JM, Perez-Garcıa R (2002) Spanish Registry of Glomerulonephritis. Frequency of renal pathology in Spain 1994–1999. Nephrol Dial Transpl 17:1594–1602CrossRef Rivera F, Lopez-Gomez JM, Perez-Garcıa R (2002) Spanish Registry of Glomerulonephritis. Frequency of renal pathology in Spain 1994–1999. Nephrol Dial Transpl 17:1594–1602CrossRef
6.
go back to reference Kasteckas M, Vaisnoras T, Laurinavicius A (2001) Pirminės glomerulopatijos Lietuvoje (1995–1999 metų inkstų bioptatų duomenų retrospektyvioji analizė). (Primary glomerulopathies in Lithuania (retrospective analysis of 1995–1999 renal biopsy data.)) Medicina (Kaunas) 37:429–32 Kasteckas M, Vaisnoras T, Laurinavicius A (2001) Pirminės glomerulopatijos Lietuvoje (1995–1999 metų inkstų bioptatų duomenų retrospektyvioji analizė). (Primary glomerulopathies in Lithuania (retrospective analysis of 1995–1999 renal biopsy data.)) Medicina (Kaunas) 37:429–32
7.
go back to reference Beitnaraite S, Kovaliunas E, Laurinavicius A (2007) Pirminės glomerulopatijos Lietuvoje (2000–2006 metų inkstų bioptatų retrospektyvioji analizė). (Primary glomerulopathies in Lithuania (retrospective analysis of 2000–2006 renal biopsy data)) Medicina (Kaunas) 43 Suppl 1:6–10 Beitnaraite S, Kovaliunas E, Laurinavicius A (2007) Pirminės glomerulopatijos Lietuvoje (2000–2006 metų inkstų bioptatų retrospektyvioji analizė). (Primary glomerulopathies in Lithuania (retrospective analysis of 2000–2006 renal biopsy data)) Medicina (Kaunas) 43 Suppl 1:6–10
8.
go back to reference Kurnatowska I, Jedrzejka D, Malyska A, Wagrowska-Danilewicz M, Danilewicz M, Nowicki M (2012) Trends in the incidence of biopsy-proven glomerular diseases in the adult population in central Poland in the years 1990–2010. Kidney Blood Press Res 35:254–258CrossRefPubMed Kurnatowska I, Jedrzejka D, Malyska A, Wagrowska-Danilewicz M, Danilewicz M, Nowicki M (2012) Trends in the incidence of biopsy-proven glomerular diseases in the adult population in central Poland in the years 1990–2010. Kidney Blood Press Res 35:254–258CrossRefPubMed
9.
go back to reference Sipiczki T, Ondrik Z, Abrahám G, Pokorny G, Turi S, Sonkodi S, Kemeny E, Ivanyi B (2004) The incidence of renal diseases as diagnosed by biopsy in Hungary. OrvHetil 145(26):1373–1379 Sipiczki T, Ondrik Z, Abrahám G, Pokorny G, Turi S, Sonkodi S, Kemeny E, Ivanyi B (2004) The incidence of renal diseases as diagnosed by biopsy in Hungary. OrvHetil 145(26):1373–1379
10.
go back to reference Polenakovic MH, Grcevska L, Dzikova S (2003) The incidence of biopsy-proven primary glomerulonephritis in the Republic of Macedonia-long-term follow-up. Nephrol Dial Transpl 18(Suppl 5):v26–v27CrossRef Polenakovic MH, Grcevska L, Dzikova S (2003) The incidence of biopsy-proven primary glomerulonephritis in the Republic of Macedonia-long-term follow-up. Nephrol Dial Transpl 18(Suppl 5):v26–v27CrossRef
11.
go back to reference Covic A, Schiller A, Volovat C, Gluhovschi G, Gusbeth-Tatomir P, Petrica L, Caruntu ID, Bozdog G, Velciov S, Trandafirescu V, Bob F, Gluhovski C (2006) Epidemiology of renal disease in Romania: a 10 year review of two regional renal biopsy databases. Nephrol Dial Transpl 21:419–424CrossRef Covic A, Schiller A, Volovat C, Gluhovschi G, Gusbeth-Tatomir P, Petrica L, Caruntu ID, Bozdog G, Velciov S, Trandafirescu V, Bob F, Gluhovski C (2006) Epidemiology of renal disease in Romania: a 10 year review of two regional renal biopsy databases. Nephrol Dial Transpl 21:419–424CrossRef
12.
go back to reference Briganti EM, Dowling J, Finlay M, Hill PA, Jones CL, Kincaid-Smith PS, Sinclair R, McNeil JJ, Atkins RC (2001) The incidence of biopsy-proved glomerulonephritis in Australia. Nephrol Dial Transpl 16(7):1364–1367CrossRef Briganti EM, Dowling J, Finlay M, Hill PA, Jones CL, Kincaid-Smith PS, Sinclair R, McNeil JJ, Atkins RC (2001) The incidence of biopsy-proved glomerulonephritis in Australia. Nephrol Dial Transpl 16(7):1364–1367CrossRef
13.
go back to reference AlRiyami D, AlShaaili K, AlBulushi Y, AlDhahli A, Date A (2013) The spectrum of glomerular diseases on renal biopsy: data from a single tertiary center in Oman. Oman Med J 28(3):213–215CrossRef AlRiyami D, AlShaaili K, AlBulushi Y, AlDhahli A, Date A (2013) The spectrum of glomerular diseases on renal biopsy: data from a single tertiary center in Oman. Oman Med J 28(3):213–215CrossRef
14.
go back to reference Polito MG, de Moura LA, Kirsztajn GM (2010) An overview on frequency of renal biopsy diagnosis in Brazil: clinical and pathological patterns based on 9,617 native kidney biopsies. Nephrol Dial Transpl 25:490–496CrossRef Polito MG, de Moura LA, Kirsztajn GM (2010) An overview on frequency of renal biopsy diagnosis in Brazil: clinical and pathological patterns based on 9,617 native kidney biopsies. Nephrol Dial Transpl 25:490–496CrossRef
15.
go back to reference Huraib S, Al Khader A, Shaheen FA, Abu Aisha H, Souqiyyeh MZ, Al Mohana F, Soliman M, WakeelJ Al, Mitwalli A, Al Mohaya S, Said R, Abdulhaleem Al, Menway L, Sohaibani M, Chan N (2000) The spectrum of glomerulonephritis in Saudi Arabia: the results of the Saudi registry. Saudi J Kidney Dis Transpl 11:434–441PubMed Huraib S, Al Khader A, Shaheen FA, Abu Aisha H, Souqiyyeh MZ, Al Mohana F, Soliman M, WakeelJ Al, Mitwalli A, Al Mohaya S, Said R, Abdulhaleem Al, Menway L, Sohaibani M, Chan N (2000) The spectrum of glomerulonephritis in Saudi Arabia: the results of the Saudi registry. Saudi J Kidney Dis Transpl 11:434–441PubMed
16.
go back to reference Chang JH, Kim DK, Kim HW, Park SY, Yoo TH, Kim BS, Kang SW, Choi KH, Han DS, Jeong HJ, Lee HY (2009) Changing prevalence of glomerular diseases in Korean adults: a review of 20 years of experience. Nephrol Dial Transpl 24:2406–2410CrossRef Chang JH, Kim DK, Kim HW, Park SY, Yoo TH, Kim BS, Kang SW, Choi KH, Han DS, Jeong HJ, Lee HY (2009) Changing prevalence of glomerular diseases in Korean adults: a review of 20 years of experience. Nephrol Dial Transpl 24:2406–2410CrossRef
17.
go back to reference Li LS, Liu ZH (2004) Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. Kidney Int 66:920–923CrossRefPubMed Li LS, Liu ZH (2004) Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. Kidney Int 66:920–923CrossRefPubMed
18.
go back to reference Naumovic R, Pavlovic S, Stojkovic D, Basta-Jovanovic G, Nesic V (2009) Renal biopsy registry from a single centre in Serbia: 20 years of experience. Nephrol Dial Transpl 24:877–885CrossRef Naumovic R, Pavlovic S, Stojkovic D, Basta-Jovanovic G, Nesic V (2009) Renal biopsy registry from a single centre in Serbia: 20 years of experience. Nephrol Dial Transpl 24:877–885CrossRef
19.
go back to reference Mesquita M, Fosso C, Bakoto Sol E, Libertalis M, Corazza F, Vanden Houte K, Dratwa M (2011) Renal biopsy findings in Belgium: a retrospective single center analysis. Acta Clin Belg 66:104–109PubMed Mesquita M, Fosso C, Bakoto Sol E, Libertalis M, Corazza F, Vanden Houte K, Dratwa M (2011) Renal biopsy findings in Belgium: a retrospective single center analysis. Acta Clin Belg 66:104–109PubMed
20.
go back to reference Simon P, Ramee MP, Boulahrouz R, Stanescu C, Charasse C, Ang KS, Leonetti F, Cam G, Laruelle E, Autuly V, Rioux N (2004) Epidemiologic data of primary glomerular diseases in western France. Kidney Int 66:905–908CrossRefPubMed Simon P, Ramee MP, Boulahrouz R, Stanescu C, Charasse C, Ang KS, Leonetti F, Cam G, Laruelle E, Autuly V, Rioux N (2004) Epidemiologic data of primary glomerular diseases in western France. Kidney Int 66:905–908CrossRefPubMed
21.
go back to reference Braun N, Schweisfurth A, Lohofener C, Lange C, Gründemann C, Kundt G, Gröne HJ (2011) Epidemiology of glomerulonephritis in Northern Germany. Int Urol Nephrol 43:1117–1126CrossRefPubMed Braun N, Schweisfurth A, Lohofener C, Lange C, Gründemann C, Kundt G, Gröne HJ (2011) Epidemiology of glomerulonephritis in Northern Germany. Int Urol Nephrol 43:1117–1126CrossRefPubMed
22.
go back to reference Laurinavicius A, Gruodyte E, Priluckiene J, Razukeviciene L, Supranaviciene L, Salkus G (2003) Galimos imunokompleksinio membranoproliferacinio glomerulonefrito antigenemijos priežastys Lietuvoje (Potential causes of antigenemia in the patient with an immune complex-mediated membranoproliferative glomerulonephritis in Lithuania). Medicina (Kaunas) 39(Suppl 1):28–32 Laurinavicius A, Gruodyte E, Priluckiene J, Razukeviciene L, Supranaviciene L, Salkus G (2003) Galimos imunokompleksinio membranoproliferacinio glomerulonefrito antigenemijos priežastys Lietuvoje (Potential causes of antigenemia in the patient with an immune complex-mediated membranoproliferative glomerulonephritis in Lithuania). Medicina (Kaunas) 39(Suppl 1):28–32
23.
go back to reference Sugiyama H, Yokoyama H, Sato H, Saito T, Kohda Y, Nishi S, Tsuruya K, Kiyomoto H, Iida H, Sasaki T, Higuchi M, Hattori M, Oka K, Kagami S, Nagata M, Kawamura T, Honda M, Fukasawa Y, Fukatsu A, Morozumi K, Yoshikawa N, Yuzawa Y, Matsuo S, Kiyohara Y, Joh K, Taguchi T, Makino H (2011) Committee for Standardization of Renal Pathological Diagnosis and Working Group for Renal Biopsy Database, Japanese Society of Nephrology, Tokyo, Japan. Japan renal biopsy registry: the first nationwide, web-based, and prospective registry system of renal biopsies in Japan. Clin Exp Nephrol 15:493–503CrossRefPubMed Sugiyama H, Yokoyama H, Sato H, Saito T, Kohda Y, Nishi S, Tsuruya K, Kiyomoto H, Iida H, Sasaki T, Higuchi M, Hattori M, Oka K, Kagami S, Nagata M, Kawamura T, Honda M, Fukasawa Y, Fukatsu A, Morozumi K, Yoshikawa N, Yuzawa Y, Matsuo S, Kiyohara Y, Joh K, Taguchi T, Makino H (2011) Committee for Standardization of Renal Pathological Diagnosis and Working Group for Renal Biopsy Database, Japanese Society of Nephrology, Tokyo, Japan. Japan renal biopsy registry: the first nationwide, web-based, and prospective registry system of renal biopsies in Japan. Clin Exp Nephrol 15:493–503CrossRefPubMed
24.
go back to reference Röcken C, Shakespeare A (2002) Pathology, diagnosis and pathogenesis of AA amyloidosis. Virchows Arch 440(2):111–122CrossRefPubMed Röcken C, Shakespeare A (2002) Pathology, diagnosis and pathogenesis of AA amyloidosis. Virchows Arch 440(2):111–122CrossRefPubMed
25.
go back to reference Gillmore JD, Hawkins PN (2013) Pathophysiology and treatment of systemic amyloidosis. Nat Rev Nephrol 9(10):574–586CrossRefPubMed Gillmore JD, Hawkins PN (2013) Pathophysiology and treatment of systemic amyloidosis. Nat Rev Nephrol 9(10):574–586CrossRefPubMed
26.
go back to reference Miglinas M, Grubinskaite E, Beitnaraite S, Alekniene D, Laurinavicius A (2010) 1998–2008 metųimunoglobulino A nefropatijos klinikinių formų paplitimo Lietuvoje retrospektyvi analizė (The incidence of clinical forms of immunoglobulin A nephropathy retrospective analysis in 1998–2008 year). Medicinos teorija ir praktika 16(3):246–252 Miglinas M, Grubinskaite E, Beitnaraite S, Alekniene D, Laurinavicius A (2010) 1998–2008 metųimunoglobulino A nefropatijos klinikinių formų paplitimo Lietuvoje retrospektyvi analizė (The incidence of clinical forms of immunoglobulin A nephropathy retrospective analysis in 1998–2008 year). Medicinos teorija ir praktika 16(3):246–252
Metadata
Title
Nationwide renal biopsy data in Lithuania 1994–2012
Authors
Ernesta Brazdziute
Marius Miglinas
Elita Gruodyte
Janina Priluckiene
Algirdas Tamosaitis
Inga Arune Bumblyte
Vytautas Kuzminskis
Soneta Burbaickaja
Marija Sakalauskienė
Augustina Jankauskienė
Rimante Cerkauskiene
Birute Pundziene
Arvydas Laurinavicius
Publication date
01-04-2015
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 4/2015
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-015-0927-y

Other articles of this Issue 4/2015

International Urology and Nephrology 4/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.